Peringatan Keamanan

There is no information available regarding acute toxicity (LD50) and overdose of trofinetide.

Trofinetide

DB06045

small molecule approved investigational

Deskripsi

Trofinetide is a novel synthetic analog of glypromate, also known as glycine–proline–glutamate (GPE), a naturally occurring protein in the brain and the N-terminal tripeptide of insulin-like growth factor 1 (IGF-1).A258438 Trofinetide was approved by the FDA on March 10, 2023, for the treatment of Rett syndrome,L45718,L45748 which is an X-linked neurodevelopmental disorder characterized by a range of cognitive, motor, and autonomic symptoms.A258438 Trofinetide is believed to work by reducing inflammation and apoptosis of neurons.A258453

Struktur Molekul 2D

Berat 315.326
Wujud solid

Peta Jejaring Molekuler
Legenda: ObatTargetGenEnzim(Panah → menunjukkan arah efek / relasi)TransporterCarrier

Profil Farmakokinetik

Waktu Paruh (Half-Life) The effective elimination half-life of orally administered trofinetide in healthy subjects is about 1.5 hours.[L45628]
Volume Distribusi Following oral administration, the apparent volume of distribution of trofinetide in healthy adult subjects was approximately 80 L. Minimal to no accumulation was observed following multiple-dose administration.[L45628]
Klirens (Clearance) No information is available.

Absorpsi

Systemic exposure to trofinetide was dose-proportional across the studied dose range. The Tmax is about two to three hours after administration. Based on the mass balance study, at least 84% of the administered oral dose of 12,000 mg trofinetide was absorbed.L45628 A high-fat meal had negligible effects on drug exposure and reduced the Cmax by approximately 20%.L45628

Metabolisme

Trofinetide is not significantly metabolized by CYP450 enzymes. Hepatic metabolism is not a significant route of trofinetide elimination.L45628

Rute Eliminasi

Trofinetide is primarily excreted in urine, with minor excretion in feces. Approximately 80% of the dose recovered in urine was in the unchanged parent drug form.L45628

Interaksi Makanan

1 Data
  • 1. Take with or without food. Food decreases Cmax of trofinetide but has negligible effects on total drug exposure.

Interaksi Obat

242 Data
Lomitapide The metabolism of Lomitapide can be decreased when combined with Trofinetide.
Eluxadoline The serum concentration of Eluxadoline can be increased when it is combined with Trofinetide.
Pravastatin The serum concentration of Pravastatin can be increased when it is combined with Trofinetide.
Valsartan The serum concentration of Valsartan can be increased when it is combined with Trofinetide.
Erythromycin The serum concentration of Erythromycin can be increased when it is combined with Trofinetide.
Torasemide The serum concentration of Torasemide can be increased when it is combined with Trofinetide.
Lovastatin The metabolism of Lovastatin can be decreased when combined with Trofinetide.
Mesalazine The serum concentration of Mesalazine can be increased when it is combined with Trofinetide.
Liothyronine The serum concentration of Liothyronine can be increased when it is combined with Trofinetide.
Conjugated estrogens The serum concentration of Conjugated estrogens can be increased when it is combined with Trofinetide.
Digoxin The serum concentration of Digoxin can be increased when it is combined with Trofinetide.
Cerivastatin The serum concentration of Cerivastatin can be increased when it is combined with Trofinetide.
Raloxifene The serum concentration of Raloxifene can be increased when it is combined with Trofinetide.
Caspofungin The serum concentration of Caspofungin can be increased when it is combined with Trofinetide.
Bosentan The serum concentration of Bosentan can be increased when it is combined with Trofinetide.
Methotrexate The serum concentration of Methotrexate can be increased when it is combined with Trofinetide.
Enalapril The serum concentration of Enalapril can be increased when it is combined with Trofinetide.
Simvastatin The serum concentration of Simvastatin can be increased when it is combined with Trofinetide.
Sumatriptan The serum concentration of Sumatriptan can be increased when it is combined with Trofinetide.
Mycophenolate mofetil The serum concentration of Mycophenolate mofetil can be increased when it is combined with Trofinetide.
Penicillamine The serum concentration of Penicillamine can be increased when it is combined with Trofinetide.
Repaglinide The serum concentration of Repaglinide can be increased when it is combined with Trofinetide.
Dinoprostone The serum concentration of Dinoprostone can be increased when it is combined with Trofinetide.
Fexofenadine The serum concentration of Fexofenadine can be increased when it is combined with Trofinetide.
Ezetimibe The serum concentration of Ezetimibe can be increased when it is combined with Trofinetide.
Benzylpenicillin The serum concentration of Benzylpenicillin can be increased when it is combined with Trofinetide.
Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Trofinetide.
Ouabain The serum concentration of Ouabain can be increased when it is combined with Trofinetide.
Fluvastatin The serum concentration of Fluvastatin can be increased when it is combined with Trofinetide.
Rosuvastatin The serum concentration of Rosuvastatin can be increased when it is combined with Trofinetide.
Liotrix The serum concentration of Liotrix can be increased when it is combined with Trofinetide.
Cholic Acid The serum concentration of Cholic Acid can be increased when it is combined with Trofinetide.
Taurocholic acid The serum concentration of Taurocholic acid can be increased when it is combined with Trofinetide.
Atrasentan The serum concentration of Atrasentan can be increased when it is combined with Trofinetide.
Simeprevir The serum concentration of Simeprevir can be increased when it is combined with Trofinetide.
Ambrisentan The serum concentration of Ambrisentan can be increased when it is combined with Trofinetide.
Axitinib The serum concentration of Axitinib can be increased when it is combined with Trofinetide.
Gimatecan The serum concentration of Gimatecan can be increased when it is combined with Trofinetide.
Temocapril The serum concentration of Temocapril can be increased when it is combined with Trofinetide.
Cholecystokinin The serum concentration of Cholecystokinin can be increased when it is combined with Trofinetide.
Gadoxetic acid The serum concentration of Gadoxetic acid can be increased when it is combined with Trofinetide.
Technetium Tc-99m mebrofenin The serum concentration of Technetium Tc-99m mebrofenin can be increased when it is combined with Trofinetide.
Fimasartan The serum concentration of Fimasartan can be increased when it is combined with Trofinetide.
Paritaprevir The serum concentration of Paritaprevir can be increased when it is combined with Trofinetide.
Tenofovir alafenamide The serum concentration of Tenofovir alafenamide can be increased when it is combined with Trofinetide.
Selexipag The serum concentration of Selexipag can be increased when it is combined with Trofinetide.
Grazoprevir The serum concentration of Grazoprevir can be increased when it is combined with Trofinetide.
Asunaprevir The serum concentration of Asunaprevir can be increased when it is combined with Trofinetide.
Revefenacin Trofinetide may decrease the excretion rate of Revefenacin which could result in a higher serum level.
Elagolix The serum concentration of Elagolix can be increased when it is combined with Trofinetide.
Voxilaprevir The serum concentration of Voxilaprevir can be increased when it is combined with Trofinetide.
Letermovir The serum concentration of Letermovir can be increased when it is combined with Trofinetide.
Brincidofovir The serum concentration of Brincidofovir can be increased when it is combined with Trofinetide.
Levosalbutamol The serum concentration of Levosalbutamol can be increased when it is combined with Trofinetide.
Glecaprevir The serum concentration of Glecaprevir can be increased when it is combined with Trofinetide.
Belantamab mafodotin The serum concentration of Belantamab mafodotin can be increased when it is combined with Trofinetide.
Atogepant The serum concentration of Atogepant can be increased when it is combined with Trofinetide.
Azithromycin The metabolism of Azithromycin can be decreased when combined with Trofinetide.
Ziprasidone The metabolism of Ziprasidone can be decreased when combined with Trofinetide.
Methysergide The metabolism of Methysergide can be decreased when combined with Trofinetide.
Terfenadine The metabolism of Terfenadine can be decreased when combined with Trofinetide.
Meperidine The metabolism of Meperidine can be decreased when combined with Trofinetide.
Chlorpromazine The metabolism of Chlorpromazine can be decreased when combined with Trofinetide.
Albendazole The metabolism of Albendazole can be decreased when combined with Trofinetide.
Cephalexin The metabolism of Cephalexin can be decreased when combined with Trofinetide.
Doxazosin The metabolism of Doxazosin can be decreased when combined with Trofinetide.
Cisapride The metabolism of Cisapride can be decreased when combined with Trofinetide.
Astemizole The metabolism of Astemizole can be decreased when combined with Trofinetide.
Norethisterone The metabolism of Norethisterone can be decreased when combined with Trofinetide.
Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Trofinetide.
Atazanavir The metabolism of Atazanavir can be decreased when combined with Trofinetide.
Pimozide The metabolism of Pimozide can be decreased when combined with Trofinetide.
Amiodarone The metabolism of Amiodarone can be decreased when combined with Trofinetide.
Fosphenytoin The metabolism of Fosphenytoin can be decreased when combined with Trofinetide.
Drospirenone The metabolism of Drospirenone can be decreased when combined with Trofinetide.
Allylestrenol The metabolism of Allylestrenol can be decreased when combined with Trofinetide.
Zuclopenthixol The metabolism of Zuclopenthixol can be decreased when combined with Trofinetide.
Roflumilast The serum concentration of Roflumilast can be increased when it is combined with Trofinetide.
Pretomanid The metabolism of Pretomanid can be decreased when combined with Trofinetide.
Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Trofinetide.
Pimavanserin The metabolism of Pimavanserin can be decreased when combined with Trofinetide.
Lacosamide The metabolism of Lacosamide can be decreased when combined with Trofinetide.
Fosaprepitant The metabolism of Fosaprepitant can be decreased when combined with Trofinetide.
Linagliptin The metabolism of Linagliptin can be decreased when combined with Trofinetide.
Vorapaxar The metabolism of Vorapaxar can be decreased when combined with Trofinetide.
Suvorexant The metabolism of Suvorexant can be decreased when combined with Trofinetide.
Netupitant The metabolism of Netupitant can be decreased when combined with Trofinetide.
Idelalisib The metabolism of Idelalisib can be decreased when combined with Trofinetide.
Ceritinib The metabolism of Ceritinib can be decreased when combined with Trofinetide.
Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Trofinetide.
Nintedanib The metabolism of Nintedanib can be decreased when combined with Trofinetide.
Osimertinib The metabolism of Osimertinib can be decreased when combined with Trofinetide.
Dihydroergocornine The metabolism of Dihydroergocornine can be decreased when combined with Trofinetide.
Isavuconazole The metabolism of Isavuconazole can be decreased when combined with Trofinetide.
Ribociclib The metabolism of Ribociclib can be decreased when combined with Trofinetide.
Ebastine The metabolism of Ebastine can be decreased when combined with Trofinetide.
Infigratinib The metabolism of Infigratinib can be decreased when combined with Trofinetide.
Duvelisib The metabolism of Duvelisib can be decreased when combined with Trofinetide.
Dacomitinib The metabolism of Dacomitinib can be decreased when combined with Trofinetide.
Alpelisib The metabolism of Alpelisib can be decreased when combined with Trofinetide.

Referensi & Sumber

Artikel (PubMed)
  • PMID: 35149233
    Neul JL, Percy AK, Benke TA, Berry-Kravis EM, Glaze DG, Peters SU, Jones NE, Youakim JM: Design and outcome measures of LAVENDER, a phase 3 study of trofinetide for Rett syndrome. Contemp Clin Trials. 2022 Mar;114:106704. doi: 10.1016/j.cct.2022.106704. Epub 2022 Feb 8.
  • PMID: 19157421
    Bickerdike MJ, Thomas GB, Batchelor DC, Sirimanne ES, Leong W, Lin H, Sieg F, Wen J, Brimble MA, Harris PW, Gluckman PD: NNZ-2566: a Gly-Pro-Glu analogue with neuroprotective efficacy in a rat model of acute focal stroke. J Neurol Sci. 2009 Mar 15;278(1-2):85-90. doi: 10.1016/j.jns.2008.12.003. Epub 2009 Jan 20.
  • PMID: 29489169
    Chahil G, Bollu PC: Rett Syndrome. .

Contoh Produk & Brand

Produk: 2 • International brands: 0
Produk
  • Daybue
    Solution • 200 mg / mL • Oral • Canada • Approved
  • Daybue
    Solution • 200 mg/1mL • Oral • US • Approved

Sekuens Gen/Protein (FASTA)

Sekuens dimuat saat dibutuhkan agar halaman tetap ringan.
© 2025 Digital Pharmacy Research - Universitas Esa Unggul